Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The U S Government The Dept Of Veterans Affairs has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being handled by 1 distinct examiner. The presence of 1 distinct art unit indicates that the current prosecution is focused on a specific technical niche within the biotechnology sector. This centralized approach allows the applicant to concentrate its efforts on a single set of technical requirements and examiner expectations.
FIEBIG, RUSSELL G is the busiest examiner, with 1 pending office action. Because there is only 1 distinct examiner for the 1 pending office action, the workload is fully concentrated. Practitioners should focus on the specific examination style of this 1 distinct art unit and the individual preferences of FIEBIG, RUSSELL G. With only 1 pending office action in the Biotechnology & Pharmaceuticals field, the company's current prosecution activity is highly targeted. This singular focus provides an opportunity to develop a robust and specific response to the examiner's findings. The outcome of this 1 pending office action will be the primary indicator of the portfolio's current success.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FIEBIG, RUSSELL G | 1 | 62.6% | +25.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18709235 | IMPROVED ADIPOSE STEM CELL-DERIVED SECRETOME THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER NEURDEGENERATIVE DISORDERS | FIEBIG, RUSSELL G | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18709235 | IMPROVED ADIPOSE STEM CELL-DERIVED SECRETOME THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER NEURDEGENERATIVE DISORDERS | FIEBIG, RUSSELL G | 1655 | §103 | Final Rejection | — | Pending | May 10, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialU S Government The Dept Of Veterans Affairs has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Russell G Fiebig has the most, with 1 of U S Government The Dept Of Veterans Affairs's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.